Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L02BG04	LETROZOLE BIOGARAN	G	Letrozole - 2.5mg	2.5mg	Tablet, coated	2,402,790 L.L
L02BG04	LETROZOLE NEAPOLIS	G	Letrozole - 2.5mg	2.5mg	Tablet, film coated	2,060,111 L.L
N03AX14	LEVETIRACETAM ARROW LAB	G	Levetiracetam - 1000mg	1000mg	Tablet, film coated, breakable	2,940,327 L.L
N03AX14	LEVETIRACETAM BIOGARAN	G	Levetiracetam - 1000mg	1000mg	Tablet, coated, scored	3,191,626 L.L
N03AX14	LEVIPHAR	G	Levetiracetam - 1000mg	1000mg	Tablet, film coated	2,212,861 L.L
N03AX14	LEVIPRAM 1000	G	Levetiracetam - 1000mg	1000mg	Tablet, film coated	1,663,805 L.L
N03AX14	LEVIPRAM IV	G	Levetiracetam - 1000mg/100ml	1000mg/100ml	Injectable solution	2,911,659 L.L
N03AX14	LEPITAM	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,336,163 L.L
N03AX14	LEVETIRACETAM ARROW	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,639,488 L.L
N03AX14	LEVETRIMED	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,336,163 L.L
N03AX14	LEVIPRAM	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,285,609 L.L
N03AX14	LEPITAM	G	Levetiracetam - 250mg	250mg	Tablet	700,078 L.L
N03AX14	LEVETIRACETAM ARROW LAB	G	Levetiracetam - 250mg	250mg	Tablet, film coated, breakable	1,243,054 L.L
N03AX14	LEVETIRACETAM BIOGARAN	G	Levetiracetam - 250mg	250mg	Tablet, coated, scored	1,350,562 L.L
N03AX14	LEVIPRAM 250	G	Levetiracetam - 250mg	250mg	Tablet, film coated	1,087,873 L.L
N03AX14	LEPITAM	G	Levetiracetam - 500mg	500mg	Tablet	1,100,671 L.L
N03AX14	LEVETIRACETAM ARROW LAB	G	Levetiracetam - 500mg	500mg	Tablet, film coated, breakable	2,441,762 L.L
N03AX14	LEVETIRACETAM BIOGARAN	G	Levetiracetam - 500mg	500mg	Tablet, coated, scored	2,651,401 L.L
N03AX14	LEVIPHAR	G	Levetiracetam - 500mg	500mg	Tablet, film coated	1,451,350 L.L
N03AX14	LEVIPRAM 500	G	Levetiracetam - 500mg	500mg	Tablet, film coated	1,663,805 L.L
N03AX14	LEVIPRAM IV	G	Levetiracetam - 500mg/100ml	500mg/100ml	Injectable solution	1,869,733 L.L
S01GX02	LEVOPHTA	B	Levocabastine HCl - 0.5mg/ml	0.05%	Suspension	682,672 L.L
R06AE09	LEVOTREX	G	Levocetirizine dihydrochloride - 5mg	5mg	Tablet, film coated	447,948 L.L
R06AE09	LIVIDA	G	Levocetirizine dihydrochloride - 5mg	5mg	Tablet, film coated	447,948 L.L
J01MA12	LEFLUMAX	G	Levofloxacin (hemihydrate) - 500mg	500mg	Tablet, film coated	752,552 L.L
J01MA12	LEVOKEY 500	G	Levofloxacin (hemihydrate) - 500mg	500mg	Tablet, film coated	141,103 L.L
J01MA12	LEVOMED	G	Levofloxacin (hemihydrate) - 500mg	500mg	Tablet	849,820 L.L
J01MA12	LOXOF	G	Levofloxacin (hemihydrate) - 500mg	500mg	Tablet, film coated	141,103 L.L
J01MA12	LEVOFLOXACIN COOPER	G	Levofloxacin (hemihydrate) - 500mg/100ml	500mg/100ml	Injectable solution	959,504 L.L
J01MA12	LEFLUMAX	G	Levofloxacin (hemihydrate) - 750mg	750mg	Tablet, film coated	1,006,538 L.L

...